本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Cogent Biosciences, Inc.

10.86
-0.1100-1.00%
盤後11.070.2100+1.93%17:14 EDT
成交量:173.21萬
成交額:1,856.05萬
市值:15.15億
市盈率:-4.35
高:10.97
開:10.87
低:10.38
收:10.97
資料載入中...
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

重要事件披露

Form 8-K - Current report
2024/02/13

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/09

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/05

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/12/11

重要事件披露

Form 8-K - Current report
2023/11/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/02

重要事件披露

Form 8-K - Current report
2023/08/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/08

重要事件披露

Form 8-K - Current report
2023/08/08

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/06/14

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/06/08

重要事件披露

Form 8-K - Current report
2023/06/08

重要事件披露

Form 8-K - Current report
2023/06/06

重要事件披露

Form 8-K - Current report
2023/06/01

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/05/09

重要事件披露

8-K - Current report
2023/05/09

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/03/14

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2023/03/14

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]